Biohaven Ltd.
BHVN
$9.29
$0.171.86%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -780.11M | -766.97M | -888.60M | -846.42M | -804.34M |
| Total Depreciation and Amortization | 9.81M | 8.68M | 8.66M | 7.86M | 7.29M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 115.62M | 84.52M | 248.17M | 239.30M | 256.35M |
| Change in Net Operating Assets | 5.17M | 28.70M | -13.17M | 16.81M | 14.11M |
| Cash from Operations | -649.52M | -645.08M | -644.94M | -582.45M | -526.59M |
| Capital Expenditure | -756.00K | -1.35M | -4.07M | -4.05M | -4.47M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | -391.00K | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 227.38M | -30.39M | -109.67M | -240.93M | -156.74M |
| Cash from Investing | 226.62M | -31.74M | -114.13M | -244.97M | -161.21M |
| Total Debt Issued | 250.00M | 250.00M | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 284.35M | 364.61M | 684.41M | 686.25M | 651.38M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -11.18M | -11.18M | -9.69M | -8.47M | -1.23M |
| Cash from Financing | 523.17M | 603.43M | 674.72M | 677.77M | 650.16M |
| Foreign Exchange rate Adjustments | 85.00K | 71.00K | 104.00K | 75.00K | -323.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.37M | -73.32M | -84.24M | -149.58M | -37.97M |